focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European stocks head for worst week since March

Fri, 23rd Jun 2023 07:42

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

EUROPEAN STOCKS HEAD FOR WORST WEEK SINCE MARCH (0638 GMT)

European futures are heading for their worst week of losses since March's banking turmoil.

Futures on the Eurostoxx are down 0.4% while Germany's DAX futures are falling 0.6%. FTSE futures are down 0.2%.

The STOXX 600 has already shed 2.6% this week as investors digested more interest rate hikes from central banks and the prospect of higher inflation for longer.

Investors are ramping up their bets on a UK recession after the Bank of England delivered a 50 bps hike on Thursday. Even so, British retail sales unexpectedly rose in May.

Meanwhile Japan's core consumer inflation exceeded forecasts in May and an index excluding fuel costs rose at the fastest annual pace in 42 years. The Fed's Powell said on Thursday the central bank would move interest rates at a "careful pace" from here.

Eyes will be on French smart label maker SES Imagotag, whose shares were suspended on Thursday after a shortselling report on its accounts that the company rejected. Italy's Eni , together with its Norwegian unit Var, agreed to buy private-equity backed Neptune Energy in a $4.9 billion deal.

GSK Plc will also be in the spotlight after the British pharmaceutical company said it reached a confidential settlement of a litigation in the United States over claims its heartburn drug Zantac caused cancer.

(Lucy Raitano)

FRAGILE MARKETS WAIT ON PMIS (0622 GMT)

A red tide swept over Asia-session screens on Friday as markets took a hot Japanese inflation reading and the Bank of England's super-sized rate hike as bad news for growth.

Japan's Nikkei looks set to snap a 10-week winning streak and the MSCI Asia ex-Japan index was poised for its worst week of the year, as rates and inflation look higher for longer.

The yen earned some reprieve, but it's shaky and at 143 to the dollar is firmly in intervention-watch territory.

Sterling had already failed to hold on to much of the boost from the Old Lady of Threadneedle Street's hawkish turn, as bond markets see the economic fallout from high rates being deleterious, and it slid further against a rising dollar on Friday.

The Aussie, a growth bellwether, is quickly unwinding a two-week rally and Aussie stocks are down 3% in three days.

The sour turn leaves markets in a delicate spot ahead of global purchasing managers' index surveys due through the day.

Softening is already broadly expected, but, in this sort of mood, any surprise could be taken badly, as solid numbers may only augur more hikes and higher rates. British retail sales figures are also due and expected to show contraction.

Chinese markets were closed on Friday for a holiday, but FTSE China futures were down almost 1% and an early-month rally on stimulus hopes has all but faded away, leaving investors feeling besieged by bad news.

In emerging markets, it's a long way to the weekend for the Turkish Lira which is crumbling as a 650 basis point rate hike on Thursday fell far short of market expectations and was seen as a sign of the political limits on monetary policy.

Key developments that could influence markets on Friday:

Europe, UK and U.S. PMIs

UK Retail Sales

(Tom Westbrook)

More News
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.